Coldstream Capital Management Inc. Purchases 21,004 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Coldstream Capital Management Inc. boosted its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 188.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 32,159 shares of the pharmacy operator’s stock after buying an additional 21,004 shares during the period. Coldstream Capital Management Inc.’s holdings in Walgreens Boots Alliance were worth $288,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. M&T Bank Corp boosted its position in shares of Walgreens Boots Alliance by 69.9% during the 3rd quarter. M&T Bank Corp now owns 200,158 shares of the pharmacy operator’s stock valued at $1,794,000 after acquiring an additional 82,352 shares during the last quarter. XTX Topco Ltd lifted its position in Walgreens Boots Alliance by 382.5% during the third quarter. XTX Topco Ltd now owns 333,969 shares of the pharmacy operator’s stock valued at $2,992,000 after purchasing an additional 264,754 shares during the last quarter. EP Wealth Advisors LLC lifted its position in Walgreens Boots Alliance by 96.6% during the third quarter. EP Wealth Advisors LLC now owns 21,786 shares of the pharmacy operator’s stock valued at $195,000 after purchasing an additional 10,707 shares during the last quarter. Kovitz Investment Group Partners LLC increased its holdings in shares of Walgreens Boots Alliance by 107.1% in the 3rd quarter. Kovitz Investment Group Partners LLC now owns 56,508 shares of the pharmacy operator’s stock worth $506,000 after buying an additional 29,219 shares during the last quarter. Finally, Wellington Management Group LLP raised its position in shares of Walgreens Boots Alliance by 193.4% during the 3rd quarter. Wellington Management Group LLP now owns 193,526 shares of the pharmacy operator’s stock valued at $1,734,000 after buying an additional 127,558 shares in the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

Shares of WBA stock opened at $10.39 on Monday. The company has a market capitalization of $8.98 billion, a P/E ratio of -1.04, a P/E/G ratio of 1.36 and a beta of 0.66. The company’s 50-day simple moving average is $9.27 and its two-hundred day simple moving average is $10.69. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $27.05. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.03. The company had revenue of $37.50 billion for the quarter, compared to analysts’ expectations of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. Walgreens Boots Alliance’s revenue was up 5.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.67 earnings per share. As a group, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 9.62%. The ex-dividend date of this dividend was Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -9.99%.

Wall Street Analyst Weigh In

Several research analysts recently commented on the company. JPMorgan Chase & Co. dropped their price target on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. UBS Group lifted their target price on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, October 17th. Evercore ISI increased their price target on Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a report on Wednesday, October 16th. Jefferies Financial Group dropped their price objective on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Finally, Bank of America reduced their target price on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research note on Wednesday, September 4th. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average price target of $12.58.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.